
According to data from Benzinga Pro, during Q1, Enfusion's (NYSE:ENFN) reported sales totaled $34.14 million. Despite a 95.74% increase in earnings, the company posted a loss of $12.52 million. In Q4, Enfusion brought in $31.85 million in sales but lost $293.89 million in earnings.